EBF1 and B-cell chronic lymphocytic leukemia: We confirmed the predicted loss of EBF1 at the intronic H464 enhancer by ChIP‐seq and determined a global CLL‐specific EBF1 binding pattern (Fig 6E, Appendix Fig S8 and Table S3).